poltland.blogg.se

Covid vaccine rush hospital
Covid vaccine rush hospital




covid vaccine rush hospital

Of 49 197 employees who received the first dose of a COVID-19 vaccine, 12 464 (25%) received the Pfizer-BioNtech vaccine and 36 733 (75%) received the Moderna vaccine. Statistical analyses were conducted using SAS, version 9.4 (SAS Institute), and statistical significance was set at P < .05. We calculated the number and frequency of self-reported cutaneous reactions with 95% confidence intervals using symptom survey respondents by dose as the denominator. Cutaneous reactions included rash or itching (other than the injection site), hives, and/or swelling of the lips, tongue, eyes, or face (eAppendix in the Supplement). For 3 days after vaccination, employees completed daily symptom surveys through a multipronged approach, including email, text message, phone, and smartphone application links. Institutional review board approval was provided by the Mass General Brigham human research committee with a waiver of informed consent. We prospectively studied Mass General Brigham employees who received an mRNA COVID-19 vaccine (first dose: December 16, 2020, to Janufollow-up through FebrueMethods in the Supplement).

covid vaccine rush hospital

Shared Decision Making and Communication.Scientific Discovery and the Future of Medicine.Health Care Economics, Insurance, Payment.Clinical Implications of Basic Neuroscience.Challenges in Clinical Electrocardiography.






Covid vaccine rush hospital